Single-stage reconstruction for knees with multiple torn ligaments

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, interventional clinical comparison of adults (>18) who underwent one-time single-stage reconstruction for multiligament knee injuries using either allograft or autograft tissue. Patients receive clinical and radiologic follow-up, including dynamic radiography to measure postoperative laxity in anterior, posterior, varus and valgus planes. The study excludes cases with associated femur or tibia fractures, neurological or vascular trauma, prior surgery on the affected knee, or ligament injury in the opposite knee. Data will be used to describe clinical outcomes and quantify differences in postoperative laxity between the two graft types.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients operated for one-time allograft or autograft reconstruction of multiligamentous knee injury
* \>18 years old

Exclusion Criteria:

* Neurological or vascular injury during trauma.
* Fracture of the femur or both bones of the leg.
* Ligamentous lesion on the contralateral knee.
* History of surgery on the affected knee.

Where it's running

• CH de Versailles
  Le Chesnay, France Recruiting

Study contacts

• Study coordinator: Nicolas Pujol
• Email: npujol@ch-versailles.fr
• Phone: 0139639565

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Observatory of adults with Ph+ ALL receiving BCR-ABL1 inhibitors with chemotherapy, steroids, or monoclonal antibodies

  This study follows adults with Philadelphia-positive acute lymphoblastic leukemia who are being treated with a combination of BCR-ABL1 inhibitors and other therapies to see how they fare in real-world practice.

  Recruiting at 7 sites Versailles Hospital · Amiens and 22 other locations · NCT07684131

• Preventive amiodarone after out-of-hospital cardiac arrest with an initial shockable rhythm

  This will try whether giving amiodarone for 72 hours to adults admitted to intensive care after an out-of-hospital cardiac arrest with a shockable rhythm reduces death or severe ventricular arrhythmia within 30 days.

  Recruiting at 25 sites Phase 3 Versailles Hospital · Amiens and 28 other locations · NCT06835491

• Adapting a fatigue-management program for adults with sickle cell disease

  This trial will test a combined cognitive-behavioral and energy-conservation program (Drépa-FACETS) to reduce fatigue in French-speaking adults with sickle cell disease.

  Recruiting Versailles Hospital · Grenoble and 1 other locations · NCT06650813

• Observing patients with severe COPD exacerbations in the ICU

  This study looks at patients with severe COPD flare-ups in the ICU to learn more about their health, treatments, and chances of recovery.

  Recruiting at 4 sites Versailles Hospital · Grenoble and 3 other locations · NCT06257329

• Understanding patient experiences after severe seizures

  This study looks at the long-term experiences and challenges faced by people who have survived severe seizures to see how it affects their daily lives and well-being.

  Recruiting at 15 sites Versailles Hospital · Angoulême and 18 other locations · NCT06100978

• Observational registry for COPD patients in ICU

  This study is looking at patients with severe COPD who are in the ICU to see how they are treated and what happens to them, in hopes of improving care for future patients.

  Recruiting Versailles Hospital · Le Chesnay · NCT05734365

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.